Showing results (261-270 of 952) with videos related to

Sort By:
Pageof 96
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 17, 2012
Comparative effectiveness research paradigm: implications for systematic reviews and clinical practice guidelinesMelissa C Brouwers, Lehana Thabane, David Moher, et al.
JAMA|March 9, 2006
Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statementGilda Piaggio, Diana R Elbourne, Douglas G Altman, et al.
Plos One|May 31, 2014
Sharing individual participant data from clinical trials: an opinion survey regarding the establishment of a central repositoryCatrin Tudur Smith, Kerry Dwan, Douglas G Altman, et al.
The American Journal of Cardiology|August 19, 2015
Reporting of a Publicly Accessible Protocol and Its Association With Positive Study Findings in Cardiovascular Trials (from the Epidemiological Study of Randomized Trials [ESORT])Ayodele Odutayo, Douglas G Altman, Sally Hopewell, et al.
JAMA|December 27, 2012
Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statementGilda Piaggio, Diana R Elbourne, Stuart J Pocock, et al.
Plos One|December 27, 2014
Multi-reader multi-case studies using the area under the receiver operator characteristic curve as a measure of diagnostic accuracy: systematic review with a focus on quality of data reportingThaworn Dendumrongsup, Andrew A Plumb, Steve Halligan, et al.
The Cochrane Database of Systematic Reviews|January 21, 2011
Comparison of protocols and registry entries to published reports for randomised controlled trialsKerry Dwan, Douglas G Altman, Lynne Cresswell, et al.
Trials|December 7, 2011
Reporting of participant flow diagrams in published reports of randomized trialsSally Hopewell, Allison Hirst, Gary S Collins, et al.
Obstetrics and Gynecology|March 31, 2004
Assisted reproductive technology and the incidence of ovarian cancer: a meta-analysisSonya Kashyap, David Moher, Michael Fung Kee Fung, et al.
Clinical Epidemiology|December 30, 2020
Retraction of COVID-19 Pharmacoepidemiology Research Could Have Been Avoided by Effective Use of Reporting GuidelinesEric I Benchimol, David Moher, Vera Ehrenstein, et al.
Pageof 96